Search Results - "Baldin, G."

Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV by Ciccullo, A, Baldin, G, Borghi, V, Cossu, M V, Giacomelli, A, Lagi, F, Farinacci, D, Iannone, V, Passerotto, R A, Capetti, A, Sterrantino, G, Mussini, C, Antinori, S, Di Giambenedetto, S

“…Abstract Objectives We aimed to investigate and compare the efficacy and safety of two dolutegravir-based two-drug regimens: dolutegravir + lamivudine versus…”
Get full text

Response of central serous chorioretinopathy evaluated by multimodal retinal imaging by Sacconi, R, Baldin, G, Carnevali, A, Querques, L, Rabiolo, A, Marchini, G, Bandello, F, Querques, G

“…Purpose To identify predictive biomarkers of treatment outcomes by multimodal retinal imaging in patients affected by central serous chorioretinopathy (CSC)…”
Get full text

Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication by Borghetti, A, Baldin, G, Lombardi, F, Ciccullo, A, Capetti, A, Rusconi, S, Sterrantino, G, Latini, A, Cossu, MV, Gagliardini, R, De Luca, A, Di Giambenedetto, S

“…Objectives We evaluated the efficacy and tolerability of lamivudine + dolutegravir in a cohort of HIV‐1 infected, treatment‐experienced patients with…”
Get full text

Hodgkin lymphoma presenting with spinal cord compression: A systematic review and clinical analysis by Angelini, A., Caldarella, G., Signori, R., Rubbo, G. Di, Baldin, G., Ruggieri, P.

Get full text

Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors by Borghetti, A, Ciccullo, A, Lombardi, F, Baldin, G, Belmonti, S, Prosperi, M, Incardona, F, Heger, E, Borghi, V, Sönnerborg, A, Zazzi, M, De Luca, A, Di Giambenedetto, S

“…Objectives Nucleoside reverse transcriptase inhibitor (NRTI) transmitted drug resistance mutations (TDRMs) could increase the risk of virological failure (VF)…”
Get full text

Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016 by Bellino, S, Borghetti, A, Lombardi, F, Camoni, L, Ciccullo, A, Baldin, G, Belmonti, S, Moschese, D, Lamonica, S, Cauda, R, Pezzotti, P, Di Giambenedetto, S

“…Here we evaluated hospitalisation rates and associated risk factors of human immunodeficiency virus (HIV)-infected individuals who were followed up in an…”
Get full text

Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy by Rabiolo, A, Zucchiatti, I, Marchese, A, Baldin, G, Sacconi, R, Montorio, D, Cicinelli, M V, Querques, L, Bandello, F, Querques, G

“…Purpose To correlate function and structural optical coherence tomography (OCT) to optical coherence tomography angiography (OCT-A) measures in patients…”
Get full text

Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study by Baldin, G, Ciccullo, A, Capetti, A, Rusconi, S, Sterrantino, G, Cossu, MV, Giacomelli, A, Lagi, F, Latini, A, Bagella, P, De Luca, A, Di Giambenedetto, S, Madeddu, G

“…Objectives The aim of the study was to compare the efficacy and tolerability of switching antiretroviral therapy to dolutegravir + emtricitabine/tenofovir…”
Get full text

Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy by Borghetti, A, Baldin, G, Ciccullo, A, Gagliardini, R, D'Avino, A, Mondi, A, Ciccarelli, N, Lamonica, S, Fanti, I, Trecarichi, E, Fabbiani, M, Cauda, R, De Luca, A, Di Giambenedetto, S

Get full text

Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors or non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: A multicenter retrospective cohort study by Lagi, F., Baldin, G., Colafigli, M., Capetti, A., Madeddu, G., Kiros, S. Tekle, Di Giambenedetto, S., Sterrantino, G.

“…•High prevalence of transmitted drug resistance (TDR) in acute HIV-1 patients•Good efficacy of dolutegravir (DTG)-based regimen even in the presence of…”
Get full text

Lamivudine‐based maintenance antiretroviral therapies in patients living with HIV‐1 with suppressed HIV RNA: derivation of a predictive score for virological failure by Borghetti, A, Moschese, D, Cingolani, A, Baldin, G, Speziale, D, Ciccullo, A, Lombardi, F, Emiliozzi, A, Belmonti, S, Antinori, A, Cauda, R, Di Giambenedetto, S

“…Objectives Two‐drug antiretroviral regimens based on lamivudine (3TC) plus either a protease inhibitor (PI) or dolutegravir (DTG) are becoming increasingly…”
Get full text

An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy by Ciccullo, A, Gagliardini, R, Baldin, G, Borghetti, A, Moschese, D, Emiliozzi, A, Lombardi, F, Ricci, R, Speziale, D, Pallavicini, F, Di Giambenedetto, S

“…Objectives Italy is a low‐incidence region for hepatitis A; however, during the last 2 years an increase in the incidence of hepatitis A virus (HAV) infection…”
Get full text

Five years with dolutegravir plus lamivudine as a switch strategy: much more than a positive finding by Ciccullo, A., Borghi, V., Giacomelli, A., Cossu, MV, Sterrantino, G., Latini, A., Giacometti, A., De Vito, A., Gennari, W., Madeddu, G., Capetti, A., d’Ettorre, G., Mussini, C., Rusconi, S., Di Giambenedetto, S., Baldin, G.

Get full text

P404 CAN THE BASELINE NT–PROBNP LEVEL BE USED AS A PROGNOSTIC MARKER IN PATIENTS HOSPITALIZED FOR COVID–19? A SINGLE CENTRE EXPERIENCE by Baldin, G, Di Maio, F, Todde, N, Volpi, N, Basan, L, Vannucci, V, Ruzittu, G, Pisanu, A, Seddone, S, Bua, A, Delogu, G, Favuzzi, A, Porcu, M

“…Abstract Background NT–proBNP is commonly used a reliable prognostic biomarker in heart failure. Although SARS–CoV–2 is primarily a respiratory virus, it can…”
Get full text

C87 THE SHORT–TERM PROGNOSTIC SIGNIFICANCE OF BASELINE TROPONIN LEVELS IN PATIENTS HOSPITALIZED FOR COVID–19 by Di Maio, F, Baldin, G, Todde, N, Volpi, N, Basan, L, Vannucci, V, Ruzittu, G, Pisanu, A, Seddone, S, Santoru, M, Delogu, G, Favuzzi, A, Porcu, M

“…Abstract Background Troponin (TN) is the biomarker of choice for the detection of cardiomyocite injury. Elevation of TN has been noted in COVID–19 patients…”
Get full text

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study by Mussini, Cristina, Lorenzini, Patrizia, Cozzi-Lepri, Alessandro, Marchetti, Giulia, Rusconi, Stefano, Gori, Andrea, Nozza, Silvia, Lichtner, Miriam, Antinori, Andrea, Cossarizza, Andrea, d'Arminio Monforte, Antonella

“…The CD4/CD8 ratio has been associated with the risk of AIDS and non-AIDS events. We describe trends in immunological parameters in people who underwent a…”
Get full text

Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: Table 1 by Borghetti, A., Baldin, G., Ciccullo, A., Gagliardini, R., D'Avino, A., Mondi, A., Ciccarelli, N., Lamonica, S., Fanti, I., Trecarichi, E., Fabbiani, M., Cauda, R., De Luca, A., Di Giambenedetto, S.

Get full text

Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIV by De Luca, Andrea, Lorenzini, Patrizia, Castagna, Antonella, Puoti, Massimo, Gianotti, Nicola, Castelli, Francesco, Mastroianni, Claudio, Maggiolo, Franco, Antinori, Andrea, Guaraldi, Giovanni, Lichtner, Miriam, dʼArminio Monforte, Antonella

“…To analyze the association between chronic hepatitis C virus (HCV) and cytomegalovirus (CMV) infections with type 2 diabetes in HIV-infected patients…”
Get full text

Predictors of choice of initial antifungal treatment in intraabdominal candidiasis by Lagunes, L., Borgatta, B., Martín-Gomez, M.T., Rey-Pérez, A., Antonelli, M., Righi, E., Merelli, M., Brugnaro, P., Dimopoulos, G., Garnacho-Montero, J., Colombo, A.L., Luzzati, R., Menichetti, F., Muñoz, P., Nucci, M., Scotton, G., Viscoli, C., Tumbarello, M., Bassetti, M., Rello, J., Ansaldi, F., Scarparo, C., Diaz-Martin, A., Palacios-Garcia, I., Rosin, C., Almirante, B., Baldin, G., Vena, A., Bouza, E., de Egea, V., Tascini, C., Menichetti, F., Tagliaferri, E., Sanguinetti, M., Mesini, A., Sganga, G., Busetti, M., Pumarola, T., Martin, M.T., Nouér, S.A., Pelaez, T., Raise, E., Grandesso, S., Del Bono, V., Esteves, P., Trucchi, C., Sartor, A., De Pascale, G., Posteraro, B., Esteves, P.

“…Intraabdominal candidiasis (IAC) is the second most frequent form of invasive candidiasis, and is associated with high mortality rates. This study aims to…”
Get full text

P1339 Clinical masks of aortic aneurysm: staged rupture of an aortic aneurysm under the guise of a recurrent infection by Volkova, A L, Bykov, V A, Petrova, E V, Grigoryev, V A, Tyurin, M Y U, Averkov, O V, Mednikov, G N, Baldin, D G

“…Abstract A 63-year-old man was admitted to the medical intensive care unit because of hypotension and suspected sepsis. Two months before he was admitted to…”
Get full text